Combination therapy of chemo drugs or targeting drugs with inhibitors or nucleic acid drugs targeting the GLI1-SOX2OT loop in vivo may further help in identifying novel therapeutic sensitizers for multiple regimens of cancer treatment. The gene discussed is SOX2-OT; the disease is cancer.